Sophie Delabie SRL
Sophie Delabie reported total assets of 183,627 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Apr 2026).
The score of Sophie Delabie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sophie Delabie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Apr 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
Sophie Delabie's financial analysis
- Solvency56.5%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sophie Delabie
Sophie Delabie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1004.744.707
- VAT number
- BE1004744707
- Peppol
- Registered · 0208:1004744707 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jan 2024
- Registered office
- 2830 Willebroek
- Latest accounts
- 2025 · filed on 13 Apr 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Sophie Delabie (SRL) has been based in Willebroek since 2024, active in: manufacture of medicaments. For 2025, it reports a net profit of 48,799 € and equity of 103,724 €; its revenue is not published. Its solvency stands at 56.5%, above the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sophie Delabie
Companies in the same business, of comparable size and area, outside its group.
- Abella Mar Manufacture of basic pharmaceutical products Kapellen · balance sheet 150,376 €
- Serrulata Other human health activities n.e.c. Braine-l'Alleud · balance sheet 184,052 €
- Alchemich Farma Manufacture of pharmaceutical preparations Houthalen-Helchteren · balance sheet 258,120 €
- Make IT Work Consulting Manufacture of basic pharmaceutical products Hamois · balance sheet 220,980 €
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Montefalcone Projects Manufacture of basic pharmaceutical products Maarkedal · balance sheet 207,746 €
- Wandji Pharma International Manufacture of pharmaceutical preparations Tournai · balance sheet 357,118 €
Frequently asked questions about Sophie Delabie
What is the revenue of Sophie Delabie?
Sophie Delabie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sophie Delabie?
In Belgium, the VAT number is the company number prefixed with BE: BE1004744707 for Sophie Delabie, if the company is VAT-registered. Its company number (CBE) is 1004.744.707.
Where is the registered office of Sophie Delabie?
According to the CBE register, the registered office of Sophie Delabie is in 2830 Willebroek.
What is the equity of Sophie Delabie?
At the close of the 2025 financial year, the equity of Sophie Delabie amounts to 103,724 €, a solvency of 56.5% of total assets.
Who manages Sophie Delabie?
The register lists 1 active mandates at Sophie Delabie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sophie Delabie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →